Ypsomed Holding AG

F:OWX

Business Description

Sector

Health Care

Industry

Health Care

Headquarters

Switzerland CH

Employees

2 025

IPO date

Sep 22, 2004

Ypsomed Holding AG makes drug delivery devices that help patients inject medicines at home. Its core products include insulin pens, pen needles, autoinjectors, and pump systems for people who need regular injections, especially diabetes patients and other chronic-care users. The company also develops and sells connected devices and digital tools that help patients track treatment and use their medicines correctly.

It sells these products mainly to pharmaceutical companies, healthcare providers, and patients. Some customers buy Ypsomed’s devices directly, while others use them as part of a drug company’s own treatment kit or brand. Ypsomed makes money by selling the devices themselves, supplying components and consumables, and in some cases by working with drug makers on customized delivery systems.

What makes Ypsomed different is that it sits at the intersection of pharma and medical devices. It does not make the drugs; it makes the tools that deliver them safely and conveniently. That gives the company a recurring role in long-term treatments, where patients and drug companies need reliable injection hardware, replaceable parts, and easy-to-use systems.